finerenone
Phase 3- Indications
- Chronic kidney disease, Diabetes mellitus type 1
Company intelligence / Profile preview
Consano Clinical Research conducts and manages clinical trials across various therapeutic areas including diabetes, metabolism, and chronic kidney disease. The company partners with sponsors to advance healthcare through ethical and innovative research practices focused on patient safety and data integrity.
No proprietary drugs or clinical results are reported; the company serves as an investigational site for sponsor-driven studies.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Consano Clinical Research.